DOD Rare Cancers Resource and Community Development Award | W81XWH 21 RCRP RCDA

Opportunity Information: Apply for W81XWH 21 RCRP RCDA

The DOD Rare Cancers Resource and Community Development Award (RCRP RCDA), funding opportunity number W81XWH 21 RCRP RCDA, is a Department of Defense research funding program run through the Department of the Army, USAMRAA. It was released May 18, 2021, with an original application deadline of October 15, 2021. The program sits in the Science and Technology / Research and Development category (CFDA 12.420) and provides support through grants and cooperative agreements. Eligibility is broadly defined as unrestricted, meaning applications are generally open to any type of organization, as long as any additional eligibility notes in the full announcement are met.

The main purpose of the award is to strengthen the rare cancers field by building resources and community-focused infrastructure that can accelerate research progress and, ultimately, improve outcomes for people living with rare cancers. Rather than focusing narrowly on a single laboratory discovery, the opportunity emphasizes practical, field-building tools and shared capabilities that make it easier for the rare cancers ecosystem to work together, reuse existing knowledge, and translate findings into better care.

The announcement highlights several persistent gaps that hold rare cancer research and patient care back. One major issue is weak communication and dissemination, meaning research results and clinical insights do not consistently reach the communities that could act on them, including clinicians, researchers in adjacent areas, and patient and caregiver networks. Another gap is the shortage of therapeutics and mechanistic studies that can clarify how rare cancers develop and progress, which in turn slows the identification of drug targets and the creation of effective treatments. The program also points to a lack of foundational research and clinical resources, such as access to patient tissues and well-characterized cell and tumor models, which are essential for validating hypotheses and testing potential therapies. Finally, it underscores the absence of robust infrastructure for sharing data and other resources, a problem that is especially damaging in rare cancers because patient populations are small and evidence is easily fragmented across institutions.

In response to those gaps, the core intent of the RCDA is to fund platforms that organize and share resources and knowledge related to rare cancers. The platform concept is broad, but the key idea is to create structured ways to catalog, distribute, and connect information about available experimental models, relevant molecular pathways, and therapeutic approaches. By making these assets easier to find, compare, and access, the award aims to reduce duplication, speed up collaboration, and help stakeholders build on each other's work instead of operating in isolated pockets.

A defining feature of the opportunity is its community orientation. The platforms supported are meant to facilitate collaboration and information sharing among a wide range of stakeholders, not just researchers. This includes patients, caregivers, and clinicians, along with other members of the rare cancers community. In practice, that emphasis signals that successful projects are expected to consider how different audiences will use the platform, how information will be communicated in understandable and actionable ways, and how the resource will remain useful for coordinating efforts across the field.

The funding notice lists an expected four awards. It also shows an award ceiling of 0, which typically indicates the ceiling was not specified in the summarized field and would need to be confirmed in the full funding announcement or associated program guidance.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Rare Cancers Resource and Community Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 18, 2021.
• Applicants must submit their applications by Oct 15, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 4 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 21 RCRP RCDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: